Karla V Ballman

11PUBLICATIONS
103CO-AUTHORS
Nuclear engineering (incl. fuel enrichment and waste processing and storage)Gene and molecular therapyMolecular targetsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 27, 2026
Targeting macrophage ferritin heavy chain mitigates ferroptosis and lung injury in experimental acute respiratory distress syndrome.

|May 12, 2026
Lessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent Glioblastoma.

|Apr 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

|Mar 31, 2026
Less Isn't Simple: Insights From Postmastectomy Radiotherapy Deintensification Trials.

Robert W Mutter, Karla V Ballman

|Jan 16, 2026
Targeted deletion of macrophage ferritin heavy chain protects from macrophage ferroptosis in acute respiratory distress syndrome.

Suzanne Cloonan, William Zhang, Kihwan Kim

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

Pageof 2

Frequent Collaborators

3 joint publications

Denise Reinke

3 joint publications

Rachel S Heise

2 joint publications

Sean Houghton

2 joint publications

Christopher Mason